Stock Forecast

  FONAR Corporation ( FONR) Stock. Should you Buy or Sell?    $ 14.76

0.91 (5.81 %)

FONAR Corporation Analysis

Updated on 10-09-2022
Symbol FONR
Price $14.76
Beta 0.763
Volume Avg. $10.2 thousand
Market Cap $98.63 M
52 Week Range $13.56 - $19.32

FONAR Corporation opened the day at $14.76 which is +'5.81 % on yesterday's close. FONAR Corporation has a 52 week high of $19.32 and 52 week low of $13.56, which is a difference of $5.76. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $98.63 M and total net profit is $89929765 which means the company is trading at 1.10 times profit to market capitalization. Theoretically, if you were to buy FONAR Corporation for $98.63 M, it would take 15 years to get your money back. FONAR Corporation are in the Medical Devices space which will have a sweet spot and industry standard for net profit multiples.

Price Chart

1 D | All


FONAR Corporation Stock Forecast - Is FONAR Corporation a Buy or Sell?

DCF ScoreStrong Buy
ROE ScoreNeutral
ROA ScoreNeutral
DE ScoreNeutral
PE ScoreStrong Buy
PB ScoreBuy
Overall RecommendationBuy

Growth and Value

PE Ratio 9.906
Dividend Yiel 0.000
Net Profit Margin 0.112

Valuing FONAR Corporation

Price Book Value Ratio 0.653 Price To Book Ratio 0.653
Price To Sales Ratio 1.325 Price Earnings Ratio 11.806

How liquid is FONAR Corporation

Current Ratio 8.071
Quick Ratio 7.827


Debt Ratio 0.263 Debt Equity Ratio 0.347
Long Term Debt To Capitalization 0.190 Total Debt To Capitalization 0.207

Latest news about FONAR Corporation

FONAR: Balance Sheet Trends Point To A Firm Bottom Shortly

FONAR stock is trading well below book value and remains profitable which is key. Cash, liquidity and equity all continue to grow on the balance sheet.

Date : 31/08/2022

Adding To My Fonar Corporation Position

I think the financial performance has been excellent over the past three quarters. I particularly like the renewed strength of the capital structure. At the same time, the shares are cheap by some measures, and not cheap by others. For that reason, I'm "nibbling" by buying 300 more shares.

Date : 01/06/2022

FONAR Corporation: Finally Closing In On A Multi-Year Bottom

Revenue almost hits $90 million & EBIT grows by 25% to surpass $17 million in Fonar's latest fiscal year.

Date : 11/10/2021

FONAR Subsidiary, HMCA, Expands with Acquisition in Yonkers, New York

Melville, New York--(Newsfile Corp. - March 31, 2021) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, announced today that it has acquired a Stand-Up® MRI facility in Yonkers, New York, from where its diagnostic imaging management subsidiary, Health Management Company of America (HMCA) will provide non-medical management services for Comprehensive MRI of New York, P.C.Tim Damadian, president and CEO of FONAR Corporation, said, "We're very excited about this Yonkers location. Physicians have been...

Date : 31/03/2021

If You Own Fonar Corporation (FONR) Stock, Should You Sell It Now?

Blue Tower Asset Management's recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 10.4% for the quarter, outperforming the S&P 500 Index which returned 8.9% in the same quarter. You should check out Blue Tower Asset Management's top 5 stock picks for investors to buy right now, which could be the biggest winners of this year.

Date : 11/11/2020

About FONAR Corporation

CEO : Mr. Timothy Damadian
Sector : Healthcare
Industry : Medical Devices

Website :

Exchange : NASDAQ Capital Market

Description :

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.

My Newsletter

Sign Up For Updates & Newsletters